1. Research Problem Definition
1.1 Problem Statement

Adverse Drug Reactions (ADRs) are underreported, delayed in detection, and often buried in unstructured clinical or social text. This project aims to:

Automatically classify and extract drug-related side effects from biomedical and real-world textual sources using NLP and machine learning.

1.2 Research Objectives
Build a robust ADR classification pipeline using NLP.
Compare traditional ML vs transformer-based embeddings.
Evaluate performance across clinical text and social media text domains.
Develop a generalizable adverse drug event detection framework.
Improve interpretability for healthcare applications.
1.3 Research Questions
Can classical ML models (e.g., SVM, Logistic Regression in Scikit-learn) effectively detect ADRs compared to transformer models?
How does domain shift (clinical vs social media) affect ADR classification?
Which feature representations (TF-IDF, word embeddings, contextual embeddings) are most effective?
Can explainability methods improve trust in biomedical NLP systems?
2. Data Sources and Dataset Engineering
2.1 Primary Datasets

You will construct a multi-source corpus:

(A) Clinical NLP datasets
MIMIC-III clinical notes (if access granted)
n2c2 ADE datasets (shared tasks on adverse drug events)
BioCreative V CDR dataset (Chemical-Disease Relations)
(B) Social Media Data
Twitter drug side effect datasets (ADR tweets corpus)
Reddit health forums (r/AskDocs, r/Drugs)
(C) Biomedical literature
PubMed abstracts (drug-event co-occurrence extraction)
2.2 Data Labeling Strategy
Annotation schema:
ADR present (1)
No ADR (0)
Severity classification (optional extension)
mild / moderate / severe
Label sources:
Existing annotated corpora
Weak supervision (distant labeling via drug dictionaries)
Rule-based heuristic labeling (symptom lexicons)
2.3 Data Preprocessing Pipeline
Steps:
Text normalization
Lowercasing
Removal of URLs, emojis (for social media)
Medical entity normalization
Drug synonyms mapping (RxNorm / UMLS if available)
Tokenization
Word-level + subword tokenization
Stopword handling (domain-aware, not generic removal)
Lemmatization (medical-aware)
Handling imbalance (SMOTE / class weighting)
3. Feature Engineering
3.1 Baseline Features
TF-IDF vectors (unigrams, bigrams)
Bag-of-words representation
3.2 Biomedical Features
Drug lexicon features
Symptom dictionaries (e.g., SideEffect Resource DB)
Co-occurrence statistics
3.3 Embedding-Based Features
Word2Vec / FastText embeddings
BioWord embeddings (biomedical pretrained vectors)
Contextual embeddings:
BERT / BioBERT / ClinicalBERT (if extended)
4. Model Architecture
4.1 Classical Machine Learning Models (Baseline)

Implemented in Scikit-learn:

Logistic Regression
Support Vector Machines (SVM)
Random Forest
Naive Bayes (baseline comparator)
4.2 Advanced Models
Option A: Deep Learning
CNN for text classification
BiLSTM / BiGRU
Option B: Transformer-based models
BioBERT
ClinicalBERT
Fine-tuned encoder for sequence classification
4.3 Ensemble Model (PhD-Level Contribution)
Weighted ensemble of:
TF-IDF + SVM
Embedding + BiLSTM
Transformer output
4.4 Explainability Layer
SHAP (feature importance)
LIME for text explanations
Attention visualization (for transformers)
5. Experimental Design
5.1 Train/Test Strategy
70/15/15 split (train/validation/test)
Cross-domain testing:
Train on clinical → test on social media
Train on social media → test on clinical
5.2 Baseline Comparisons

Compare:

TF-IDF + Logistic Regression
TF-IDF + SVM
Embedding + BiLSTM
Transformer fine-tuning
5.3 Hyperparameter Optimization
Grid Search (classical models)
Bayesian optimization (advanced models)
5.4 Evaluation Metrics
Accuracy (secondary metric)
Precision / Recall / F1-score (primary)
ROC-AUC
PR-AUC (important for imbalanced ADR detection)
Confusion matrix analysis
6. Results Analysis
6.1 Performance Breakdown
Per-class ADR detection performance
False positive vs false negative analysis
6.2 Domain Generalization Study
Clinical vs social media transfer performance
Domain drift quantification
6.3 Error Analysis
Negation detection failures ("no side effects observed")
Ambiguous symptom mentions
Polypharmacy confusion cases
7. Discussion (PhD-Level Interpretation)
7.1 Key Findings
Classical ML performs strongly on structured biomedical text
Transformers dominate on noisy social media text
Domain adaptation is critical for real-world deployment
7.2 Clinical Implications
Early ADR detection in pharmacovigilance systems
Real-time drug safety monitoring from social media
Support for healthcare decision systems
7.3 Limitations
Dataset bias (underrepresented drugs)
Label noise in social media data
Lack of temporal modeling (drug intake vs effect timing)
7.4 Ethical Considerations
Patient privacy in clinical datasets
Social media consent issues
Risk of false clinical inference
8. Conclusion and Future Work
8.1 Conclusion

Summarize:

Best-performing model
Key contribution (ensemble + explainability + domain adaptation)
8.2 Future Work
Temporal modeling of ADR onset
Multimodal data (EHR + imaging + text)
Real-time deployment pipeline
Integration with pharmacovigilance systems (FDA FAERS-like systems)
📄 FULL DETAILED THESIS / REPORT STRUCTURE
Title Page
Title
Author
Institution
Date
Abstract (200–300 words)
Problem
Methods
Results
Contribution
Chapter 1: Introduction
Background of ADR detection
Motivation
Problem statement
Contributions
Chapter 2: Literature Review
Traditional pharmacovigilance
NLP in healthcare
Biomedical classification systems
Transformer models in medicine
Chapter 3: Data and Dataset Construction
Data sources
Annotation strategy
Preprocessing pipeline
Dataset statistics
Chapter 4: Methodology
Feature engineering
Model design
Baseline ML models
Deep learning models
Transformer models
Ensemble strategy
Explainability methods
Chapter 5: Experimental Setup
Train/test splits
Evaluation metrics
Hardware/software setup
Implementation details (Scikit-learn, PyTorch, etc.)
Chapter 6: Results
Model comparison tables
Performance graphs
Confusion matrices
Domain transfer results
Chapter 7: Discussion
Interpretation of results
Clinical relevance
Model limitations
Ethical considerations
Chapter 8: Conclusion
Summary
Contributions
Future research directions
References
Biomedical NLP papers
Drug safety literature
Machine learning references
Appendices
Code snippets
Dataset schema
Hyperparameter tables
Additional experiments